AJR Am J Roentgenol. 1994 Mar;162(3):568. doi: 10.2214/ajr.162.3.8109497.
PMID:8109497
Incidental pulmonary carcinoid tumorlet associated with lung cancer.
Tchercansky AN, Buero A, Auvieux R, Korbenfeld E, Mendez J, Chimondeguy D.
Medicina (B Aires). 2022;82(2):297-299.
PMID:35417395
Prognostic Significance of Pulmonary Multifocal Neuroendocrine Proliferation With Typical Carcinoid.
Tassi V, Scarnecchia E, Ferolla P, Mete O, Manjula M, Allison F, Potenza R, Vannucci J, Ceccarelli S, Yasufuku K, De Perrot M, Pierre A, Darling G, Colella R, Ascani S, Mattioli S, Keshavjee S, Waddell TK, Puma F, Daddi N.
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.
Sun TY, Hwang G, Pancirer D, Hornbacker K, Codima A, Lui NS, Raj R, Kunz P, Padda SK.
Eur Respir J. 2022 Jan 27;59(1):2101058. doi: 10.1183/13993003.01058-2021. Print 2022 Jan.
PMID:34795035
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up( ).
Baudin E, Caplin M, Garcia-Carbonero R, Fazio N, Ferolla P, Filosso PL, Frilling A, de Herder WW, Hörsch D, Knigge U, Korse CM, Lim E, Lombard-Bohas C, Pavel M, Scoazec JY, Sundin A, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
Ann Oncol. 2021 Apr;32(4):439-451. doi: 10.1016/j.annonc.2021.01.003. Epub 2021 Jan 19.